Fingerprint
Dive into the research topics of 'One-year outcomes from a phase 3 randomized trial of ravulizumab in adults with paroxysmal nocturnal hemoglobinuria who received prior eculizumab'. Together they form a unique fingerprint.- Sort by
- Weight
- Alphabetically